Notice of AGM

LEI: 549300Q7EXQQH6KF7Z84

21 May 2020

RTW Venture Fund Limited

Notice of Annual General Meeting

RTW Venture Fund Limited (the "Company") announces that its Annual General Meeting ("AGM") will be held at Trafalgar Court, Les Banques, St Peter Port, Guernsey on 25 June 2020 at 14.00 BST. The Notice of AGM and Form of Proxy have been dispatched to all shareholders.

A copy of the Notice of AGM and Form of Proxy have been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM. The Notice of AGM and Form of Proxy may also be viewed on the Company's website at https://www.rtwfunds.com/venture-fund/.

The Annual Report and Audited Financial Statements for the year ended 31 December 2019 (the "Annual Report") is also available on the Company's website at https://www.rtwfunds.com/wp-content/uploads/2020/04/Annual-Report-and-Audited-Financial-Statements-2019.pdf and on the National Storage Mechanism at http://www.morningstar.co.uk/uk/NSM.

The Company is closely monitoring the Covid-19 situation, including the Guernsey government guidance, and will continue to do so in the lead up to the AGM.

In light of the current Guernsey government guidance on reducing social interactions between people (social distancing) to reduce the transmission of Covid-19, and specifically the avoidance of large gatherings and non-essential travel, shareholders should carefully consider whether or not it is appropriate to attend the meeting in person this year if the guidance continues to be the same or even more restrictive. Currently, the Guernsey government have implemented a mandatory 14-day isolation period for people travelling to the island, which would make in-person attendance at the AGM impracticable. As such, the Board encourages all shareholders to appoint the Chairman of the Meeting as their proxy as early as possible in order to vote on the matters being considered at the meeting. All votes on the resolutions contained in the Notice of Annual General Meeting will be held by poll, so that all voting rights exercised by Shareholders who are entitled to do so at the AGM will be counted.

The situation is developing rapidly and shareholders should note that further changes may need to be put in place at short notice in relation to the AGM this year. Updates on the status of the AGM and any changes to the proceedings of the meeting will be published on https://www.rtwfunds.com/venture-fund/ and announced to the market. If any shareholder has questions related to the business of the AGM, please submit your queries at https://www.rtwfunds.com/venture-fund/ by 14.00 BST on 23 June 2020. We will endeavour to answer every shareholder question and responses will be posted on the Company's website after the AGM.

For Further Information

RTW Investments, LP +1 (646) 343 9280Stephanie Sirota, Chief Business Officer

Alexandra Taracanova, PhD, Director of Investor Relations

Julia Enright, Business Development Associate

Ocorian (Company Secretary) +44 (0)1481 742 642Kevin Smith

J.P. Morgan Cazenove +44 (0)20 7742 4000

William Simmonds

Oliver Kenyon

James Bouverat (Sales)

Barclays +44 (0)20 7623 2323

Tom Swerling

Andrew Tusa

Alwyn Clarke

Ryan McCarthy

About RTW Venture Fund Limited:

RTW Venture Fund Limited (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Venture Fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

RTW Venture Fund Limited is managed by RTW Investments, LP, a leading US healthcare investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.

Visit the RTW website at www.rtwfunds.com for more information.